Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. Show more
400 Seaport Court, Redwood City, CA, 94063, United States
Market Cap
26.77M
52 Wk Range
$3.10 - $15.91
Previous Close
$4.20
Open
$4.26
Volume
71,718
Day Range
$4.24 - $4.88
Enterprise Value
22.7M
Cash
4.438M
Avg Qtr Burn
-3.528M
Insider Ownership
35.38%
Institutional Own.
2.33%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Burixafor Details Multiple myeloma | Phase 2 Update |